385 filings
Page 9 of 20
8-K
hfu qbk5688fxw5z
18 Nov 19
Alkermes to Acquire Rodin Therapeutics
7:16am
8-K
ztu jw14vf8l8lfv
30 Oct 19
Biogen and Alkermes Announce FDA Approval of VUMERITY™ (diroximel fumarate) for Multiple Sclerosis
7:43am
8-K
btl5nltml62q4 xt
23 Oct 19
Alkermes Plc Reports Third Quarter 2019 Financial Results and Implementation of Restructuring
7:05am
8-K
rmmisf4em8s jqja
17 Oct 19
Regulation FD Disclosure
5:27pm
8-K
m0yckjc uk6
13 Sep 19
Departure of Directors or Certain Officers
7:22am
8-K
kqd8ac0mftii4 4ho8vx
30 Jul 19
Regulation FD Disclosure
7:46am
8-K
dmfqmf22lbqa46y3xx0w
30 Jul 19
Other Events
12:00am
S-8
tg0br1oa3s o6
25 Jul 19
Registration of securities for employees
5:23pm
8-K
fzxczqiffek3hm
25 Jul 19
Alkermes Plc Reports Second Quarter 2019 Financial Results
7:05am
8-K
r7b1 bsrr
15 Jul 19
Regulation FD Disclosure
7:33am
8-K
ruie5e brak6enu3
22 May 19
Departure of Directors or Certain Officers
4:05pm
DEFA14A
sx0zmdrzpt8p22 5wk
16 May 19
Additional proxy soliciting materials
4:19pm
DEFA14A
18aruerv
15 May 19
Additional proxy soliciting materials
12:32pm
8-K
g4m2n7h7y4c61ms8ecxa
25 Apr 19
Alkermes Plc Reports First Quarter 2019 Financial Results
7:05am
8-K
gzpdt74
8 Apr 19
Alkermes Announces Departure of Jim Robinson
5:26pm
DEFA14A
spuhwvrhncwsaxgi
5 Apr 19
Additional proxy soliciting materials
4:15pm